New MRI Biomarkers in Head and Neck Cancers

Description

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor. The purpose of this study is to see if new MRI methods can give us more information about the tumor.

Conditions

Head and Neck Cancer, Thyroid Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor. The purpose of this study is to see if new MRI methods can give us more information about the tumor.

Quantitative Imaging Tools to Derive DW-MRI Oncological Biomarkers

New MRI Biomarkers in Head and Neck Cancers

Condition
Head and Neck Cancer
Intervention / Treatment

-

Contacts and Locations

New York

Memorial Sloan Kettering Cancer Center, New York, New York, United States, 10065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥ 18 years
  • * Group 1 patients: Presence of a suspicious metastatic lesion or suspicious for recurrent disease in the head and neck region.
  • * Group 2 patients:
  • * Biopsy proven recurrent or metastatic or definitive head and neck cancer or (differentiated and undifferentiated) thyroid cancers in the head and neck region only.
  • * Patients planning to undergo reatment at MSK
  • * Patient would require anesthesia for the study
  • * Patients who are claustrophobic
  • * Patients selecting treatment outside of MSK
  • * Known reaction to Gd based contrast agent
  • * Patients who have presence of a known contradiction to MRI
  • * Pacemaker
  • * Aneurysm clips
  • * Patients with implants that are contradicted for MR imaging will be excluded
  • * Pregnant
  • * Age and mental status wherein he /she is unable to cooperate for MRI study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Amita Dave, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2025-03